Cimetidine 300 MG Oral Tablet — RxCUI 197506
RxNorm drug concept · Semantic clinical drug
RxCUI 197506
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197506
Official nameCimetidine 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped21
Package NDCs mapped35
Reported Medicaid activity (SDUD)35,067 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cimetidine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The over-the-counter tablets — brands like Acid Reducer, Equate Cimetidine, and Basic Care Acid Reducer — are intended for everyday heartburn relief and prevention. You take one ta...
- What's the difference between the OTC cimetidine tablets and the prescription version?
- It's actually best not to take them at the exact same time. Antacids can interfere with how well cimetidine is absorbed from your stomach, which means the cimetidine may not work a...
- Can I take antacids at the same time as cimetidine?
🕸️ Concept Web — How Cimetidine 300 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cimetidine 300 MG Oral Tablet
RxCUI 197506 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cimetidine
2541IN
-
Cimetidine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cimetidine Oral Tablet
371515SCDF -
Cimetidine Oral Product
1151784SCDG -
Cimetidine Pill
1151785SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Cimetidine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cimetidine 300 MG
315679SCDC
-
Cimetidine 300 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cimetidine 300 MG
SCDC · 315679 -
Cimetidine Oral Tablet
SCDF · 371515 -
Cimetidine Oral Product
SCDG · 1151784 -
Cimetidine Pill
SCDG · 1151785
📦 FDA Products & Package NDCs
21 products · 35 package NDCs
35 package NDCs map to RxCUI 197506 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-8192-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-8192-01) | Cimetidine | Teva Pharmaceuticals USA, Inc. | 2003-11-24 |
| 00093-8192-05 | 500 TABLET, FILM COATED in 1 BOTTLE (0093-8192-05) | Cimetidine | Teva Pharmaceuticals USA, Inc. | 2004-01-28 |
| 00093-8204-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-8204-01) | Cimetidine | Teva Pharmaceuticals USA, Inc. | 2004-04-07 |
| 00093-8204-05 | 500 TABLET, FILM COATED in 1 BOTTLE (0093-8204-05) | Cimetidine | Teva Pharmaceuticals USA, Inc. | 2004-02-02 |
| 00093-8305-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-8305-01) | Cimetidine | Teva Pharmaceuticals USA, Inc. | 2003-12-23 |
| 00378-0053-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0053-01) | Cimetidine | Mylan Pharmaceuticals Inc. | 1994-05-17 |
| 00378-0317-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0317-01) | Cimetidine | Mylan Pharmaceuticals Inc. | 1994-05-17 |
| 00378-0372-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0372-01) | Cimetidine | Mylan Pharmaceuticals Inc. | 1994-05-17 |
| 00378-0541-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0541-01) | Cimetidine | Mylan Pharmaceuticals Inc. | 1994-05-17 |
| 50090-0500-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-0500-0) | Cimetidine | A-S Medication Solutions | 2016-06-29 |
| 50090-0500-01 | 60 TABLET, FILM COATED in 1 BOTTLE (50090-0500-1) | Cimetidine | A-S Medication Solutions | 2016-07-26 |
| 59651-0823-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-823-01) | CIMETIDINE | Aurobindo Pharma Limited | 2024-11-12 |
| 59651-0824-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-824-01) | CIMETIDINE | Aurobindo Pharma Limited | 2024-11-12 |
| 59651-0825-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-825-01) | CIMETIDINE | Aurobindo Pharma Limited | 2024-11-12 |
| 59651-0825-05 | 500 TABLET, FILM COATED in 1 BOTTLE (59651-825-05) | CIMETIDINE | Aurobindo Pharma Limited | 2024-11-12 |
| 59651-0826-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-826-01) | CIMETIDINE | Aurobindo Pharma Limited | 2024-11-12 |
| 62135-0630-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62135-630-30) | CIMETIDINE | Chartwell RX, LLC | 2023-08-15 |
| 62135-0631-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-631-90) | CIMETIDINE | Chartwell RX, LLC | 2023-08-15 |
| 62135-0632-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-632-90) | CIMETIDINE | Chartwell RX, LLC | 2023-08-15 |
| 62135-0633-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-633-90) | CIMETIDINE | Chartwell RX, LLC | 2023-08-15 |
| 63629-1783-01 | 30 TABLET, FILM COATED in 1 BOTTLE (63629-1783-1) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-02 | 60 TABLET, FILM COATED in 1 BOTTLE (63629-1783-2) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-03 | 20 TABLET, FILM COATED in 1 BOTTLE (63629-1783-3) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-04 | 21 TABLET, FILM COATED in 1 BOTTLE (63629-1783-4) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-05 | 90 TABLET, FILM COATED in 1 BOTTLE (63629-1783-5) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-06 | 120 TABLET, FILM COATED in 1 BOTTLE (63629-1783-6) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 63629-1783-07 | 28 TABLET, FILM COATED in 1 BOTTLE (63629-1783-7) | Cimetidine | Bryant Ranch Prepack | 2005-01-19 |
| 69452-0323-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-323-20) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0323-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-323-30) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0324-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-324-20) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0324-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-324-30) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0325-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-325-20) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0325-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-325-30) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0326-20 | 100 TABLET, FILM COATED in 1 BOTTLE (69452-326-20) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
| 69452-0326-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-326-30) | Cimetidine | Bionpharma Inc. | 2025-03-01 |
Observed labelers:
Bionpharma Inc. (8) ·
Bryant Ranch Prepack (7) ·
Aurobindo Pharma Limited (5) ·
Teva Pharmaceuticals USA, Inc. (5) ·
Chartwell RX, LLC (4) ·
Mylan Pharmaceuticals Inc. (4)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.